2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Medtronic’s OsteoCool System Granted Expanded Indication by FDA for the Palliative Treatment of Metastatic Bone Tumors

February 15, 2017 -- Medtronic announced that the US Food and Drug Administration has approved an expanded indication for its OsteoCool RF Ablation System for the palliat…

One-Year Data Presented for B. Braun's SeQuent Please Over-the-Wire Drug-Coated Balloon

February 14, 2017 -- One-year clinical trial data regarding use of B. Braun Melsungen AG’s SeQuent Please Over-the-Wire (OTW) drug-coated balloon (DCB) in femoropop…

Endologix’s Ovation LUCY Study Completes Patient Enrollment

February 14, 2017 -- Endologix, Inc. announced that it has completed patient enrollment for the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal A…

Micro Medical Solutions Obtains CE Mark Approval for MicroStent Device

February 13, 2017 -- Micro Medical Solutions announced that it has obtained CE Mark approval for its MicroStent device. According to the company, MicroStent is a vascular sten…

Medtronic Launches In.Pact Admiral Drug-Coated Balloon in Canada

February 9, 2017 -- Medtronic Canada, a subsidiary of Medtronic, announced it has obtained Health Canada license for the In.Pact Admiral drug-coated balloon (DCB), a prim…

Medtronic's Drug-Coated Balloon Evaluated in the IN.PACT SFA Japan Trial

February 9, 2017 -- Medtronic announced that the 1-year clinical outcomes from the MDT-2113 IN.PACT SFA Japan trial were presented by Osamu Iida, MD, at LINC 2017, the Le…

Click here for more News coverage

Current Supplement

Sponsored by BOLTON MEDICAL

Ahead of the Curve

Current European Supplement

Sponsored by VASCUTEK LTD.

EVARlution

More options and more solutions to treat complex AAA anatomy.

Featured Video

Sponsored by Intact Vascular

Addressing Post-PTA Dissections with a Unique and Novel Approach

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $44.69  1.11%
AstraZeneca PLC $29.16  1.39%
Avinger $2.40  0.00%
Boston Scientific Corporation $25.39  0.12%
Cardinal Health $80.71  0.59%
Cardiovascular Systems Inc. $29.19  2.67%
CR Bard Inc. $242.41  0.26%
Edwards Lifesciences Corp. $89.74  -0.21%
Endologix Inc. $6.76  -1.82%
Vascular Market Price  Change
Johnson and Johnson $118.86  0.66%
Lombard Medical, Inc. $0.63  1.45%
Medtronic, Inc. $78.88  1.14%
Merit Medical Systems, Inc. $28.25  -0.35%
Penumbra, Inc. $78.75  1.09%
Stryker $126.34  0.47%
The Medicines Company $53.40  1.14%
The Spectranetics Corporation $26.70  1.33%
Vascular Solutions Inc. $56.00  0.00%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.